Cognitive-affective manifestations since premanifest phases of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease

被引:1
|
作者
Bolzan, Gabriela [1 ,2 ]
Eyng, Maria E. Mueller [3 ]
Leotti, Vanessa B. [4 ,5 ]
Saraiva-Pereira, Maria L. [1 ,6 ,7 ]
Jardim, Laura B. [1 ,6 ,8 ,9 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, Brazil
[2] Hosp Clin Porto Alegre, Ctr Pesquisa Clin & Expt, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, Brazil
[4] Univ Fed Rio Grande do Sul, Dept Estat, Porto Alegre, Brazil
[5] Univ Fed Rio Grande do Sul, Programa Posgrad Epidemiol, Porto Alegre, Brazil
[6] Hosp Clin Porto Alegre, Serv Genet Med, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
[7] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, Brazil
[8] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, Brazil
[9] Hosp Clin Porto Alegre, DMI FAMED UFRGS, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
关键词
Cerebellar Cognitive Affective; Schmahmann Syndrome; Spinocerebellar Ataxia Type 3; Machado-Joseph Disease; Cognition; Affect; MACHADO-JOSEPH-DISEASE; NEUROPATHOLOGY; DYSFUNCTION; SCALE; MIND;
D O I
10.1016/j.cortex.2023.09.021
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Background: Cognitive deficits were related to Spinocerebellar Ataxia type 3/MachadoJoseph Disease (SCA3/MJD), but the Cerebellar Cognitive Affective Syndrome (CCAS) needs further investigation in this disorder. We aimed to characterize cognitive-affective deficits in manifest and premanifest SCA3/MJD carriers.Methods: Subjects at 50% risk, manifest carriers and unrelated controls were evaluated inperson or in virtual settings with CCAS Scale (CCAS-S), Stroop Color-Word Test (SCWT), Trail-Making Test (TMT), and Reading the Mind in the Eyes Test (RMET). Scale for Assessment and Rating of Ataxia (SARA) >2.5 or Friedreich Ataxia Rating Scale/Activities of Daily Living (FARS-adl) >4 divided carriers into manifest and premanifest. Time after onset or time left to gait ataxia onset (TimeToAfterOnset) were estimated. Differences between groups and correlations with TimeToAfterOnset, SARA and FARS-adl were checked.Results: After random selection to balance groups, 23 manifest and 35 premanifest carriers, and 58 controls were included. CCAS-S, semantic fluency, phonemic fluency, category switching, affect, SCWT, and RMET showed significant differences between manifest carriers and controls; premanifest carriers mostly displayed intermediate values between controls and manifest carriers. These variables correlated with TimeToAfterOnset and SARA scores of the carriers. Correlations with SARA were stronger in the pre-ataxic group. CCAS-S had the strongest correlations with time and SARA. Discussion: Cognitive-affective deficits in SCA3/MJD involve executive function, language, affect, and social cognition, which seem to be altered prior to the ataxia onset, and correlate with markers of motor progression. CCAS-S was the most promising biomarker and should be evaluated in longitudinal studies.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 382
页数:13
相关论文
共 50 条
  • [41] SPINOCEREBELLAR ATAXIA, TYPE-3 (SCA3) IS GENETICALLY IDENTICAL TO MACHADO-JOSEPH DISEASE (MJD)
    HABERHAUSEN, G
    DAMIAN, MS
    LEWEKE, F
    MULLER, U
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1995, 132 (01) : 71 - 75
  • [42] Vergence disorders in patients with spinocerebellar ataxia 3/Machado-Joseph disease: a synoptophore study
    Ohyagi, Y
    Yamada, T
    Okayama, A
    Sakae, N
    Yamasaki, T
    Ohshima, T
    Sakamoto, T
    Fujii, N
    Kira, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2000, 173 (02) : 120 - 123
  • [43] Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease
    LopesCendes, I
    Maciel, P
    Kish, S
    Gaspar, C
    Robitaille, Y
    Clark, HB
    Koeppen, AH
    Nance, M
    Schut, L
    Silveira, I
    Coutinho, P
    Sequeiros, J
    Rouleau, GA
    ANNALS OF NEUROLOGY, 1996, 40 (02) : 199 - 206
  • [44] Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients
    Silveira, I
    LopesCendes, I
    Kish, S
    Maciel, P
    Gaspar, C
    Coutinho, P
    Botez, MI
    Teive, H
    Arruda, W
    Steiner, CE
    PintoJunior, W
    Maciel, JA
    Jain, S
    Sack, G
    Andermann, E
    Sudarsky, L
    Rosenberg, R
    MacLeod, P
    Chitayat, D
    Babul, R
    Sequeiros, J
    Rouleau, GA
    NEUROLOGY, 1996, 46 (01) : 214 - 218
  • [45] Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): A cross-sectional study
    Pedroso, Jose Luiz
    Bor-Seng-Shu, Edson
    Felicio, Andre Carvalho
    Braga-Neto, Pedro
    Teixeira, Manoel Jacobsen
    Barsottini, Orlando Graziani
    NEUROSCIENCE LETTERS, 2011, 504 (02) : 98 - 101
  • [46] A Neuropathologic Study of Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) in a 62 Year-Old Man
    Newell, Kathy L.
    Lakis, Nelli S.
    Ghetti, Bernardino
    Figueroa, Karla P.
    Pulst, Stefan M.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (06): : 573 - 573
  • [47] Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease
    Raposo, Mafalda
    Huebener-Schmid, Jeannette
    Tagett, Rebecca
    Ferreira, Ana F.
    Melo, Ana Rosa Vieira
    Vasconcelos, Joao
    Pires, Paula
    Kay, Teresa
    Garcia-Moreno, Hector
    Giunti, Paola
    Santana, Magda M.
    de Almeida, Luis Pereira
    Infante, Jon
    van de Warrenburg, Bart P.
    de Vries, Jeroen J.
    Faber, Jennifer
    Klockgether, Thomas
    Casadei, Nicolas
    Admard, Jakob
    Schoels, Ludger
    Riess, Olaf
    Costa, Maria do Carmo
    Lima, Manuela
    NEUROBIOLOGY OF DISEASE, 2024, 193
  • [48] Transcranial sonography findings in spinocerebellar ataxia type 3 (Machado-Joseph disease): a cross-sectional study
    Pedroso, J. L.
    Bor-Seng-Shu, E.
    Nogueira, R. C.
    Brambilla, F.
    Felicio, A. C.
    Braga-Neto, P.
    Dutra, L. A.
    Teixeira, M. J.
    Barsottini, O. G.
    CEREBROVASCULAR DISEASES, 2013, 35 : 29 - 29
  • [50] Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD)
    Lima, Manuela
    Raposo, Mafalda
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 309 - 319